Specifically designed to mitigate opioid withdrawal symptoms, Lucemyra (Lofexidine HCl 0.18 mg) aids in the abrupt discontinuation of opioids in adults.
Formulated as a central alpha 2-adrenergic agonist, Lucemyra effectively reduces the physical symptoms associated with opioid withdrawal.
Each bottle contains 36 tablets, providing a comprehensive course for opioid withdrawal management.
Manufactured by US WorldMeds, ensuring high-quality and reliable medication for opioid withdrawal support.
Lucemyra is a non-opioid option, offering an alternative pathway to those seeking to manage withdrawal symptoms safely.
